World Market for Cancer Diagnostics to Reach $7.4 Billion by 2009
Cancer, with its high prevalence and mortality rate, continues to rank among the world's deadliest and most costly diseases.
New York (PRWEB) October 31, 2005
The worldwide market for in vitro cancer diagnosis will reach the $7.4 billion mark by 2009, according to a new study just released by Kalorama Information. As the demand for more sophisticated diagnostics continues to grow and synergies between tests and new therapeutics emerge, IVD tests for cancer will continue to see an impressive 13% annual growth.
The new study, The Worldwide Market for Cancer Diagnostics, predicts that despite the high price tag and hesitation by payer groups—private and government based—to accept these newer diagnostic modalities, the demand for such tests will only continue to increase as the annual incidence of new cancer cases soars toward the 10 million mark.
“With continual advancements in the field of bioinformatics and the links between genes, proteins, and cancer, we are seeing a remarkable shift in approaches to the screening and monitoring of cancer,” notes Shara Rosen, the author of the report. “Couple this with an aging population, higher incidences of cancer, and the emergence of pharma-diagnostic research partnerships, and you have a recipe for a very healthy market outlook.”
Written from the point of view of in vitro diagnostic modalities for the early detection of cancer—and in particular, solid tumors— The Worldwide Market for Cancer Diagnostics thoroughly reports the demographics and epidemiology of cancer, reviews emerging technologies and products, quantifies existing markets (in terms of both cancer tests in traditional IVD segments and IVD tests in different cancer segments), and forecasts likely clinical and business scenarios in this rapidly changing industry.
The Worldwide Market for Cancer Diagnostics can be purchased directly from Kalorama Information by clicking http://www. kaloramainformation. com/pub/1099950.html (http://www. kaloramainformation. com/pub/1099950.html). It is also available at MarketResearch. com.
About Kalorama Information
Kalorama Information, a division of MarketResearch. com, supplies the latest in independent market research for the life sciences. For more information, contact Steven Heffner at 212-807-2634 or visit www. KaloramaInformation. com.
About MarketResearch. com
MarketResearch. com is the leading provider of global market intelligence products and services. With over 91,000 research publications from 350 research publishers, it’s the world’s most extensive database of expert insights on global industries. For more information, contact Tom Ehart at 301-468-3650 x.250 or visit www. MarketResearch. com.
###
